Dr. Michael Hill, Stroke Neurologist, University of Calgary

Basic Applied Science
14 followers
2 Video Views·Apr 5, 2026
Michael Hill, a neurologist at the University of Calgary, lectured on stroke, emphasizing early detection, timely intervention, and the role of revascularization therapy. He explained how to optimize emergency procedures to minimize brain damage and improve long-term recovery.
I'm Michael Hill. I'm a stroke neurologist here at Foothills Hospital in Calgary.
Timely treatment is important for all types of stroke. The goal of acute treatments, treatments
that are given in the first hours, is to restore blood flow. Very simply and conceptually, it's a
plumbing problem. You got a pipe, which is your blood vessel. It's blocked, and if you can unblock
it and restore blood flow, that gives the patient the best chance for minimizing damage to the brain
and then, of course, recovery after. So speed is really important because as soon as that blood
vessel gets blocked, damage starts to occur, and that damage is permanent. So the longer you go
with having a blocked artery, the more permanent brain damage actually occurs. The shorter it is,
whether it can spontaneously open or whether we intervene medically. We give medicines such as
tPA or alteplase, a clot-busting medicine, or whether we use a device, a retrievable stent
with endovascular therapy, to go up and pull, mechanically remove the blockage
and restore blood flow, the better it is. So speed is absolutely critical in stroke.
As a way of understanding it, the numbers on this are actually quite staggering. So
for every minute that the middle cerebral artery, which is the big main artery in the brain,
is blocked, you will lose approximately 2 million neurons per minute and 12 kilometers of axons or
wires that connect you. So that's every minute. We have been fortunately funded by
Alberta Innovates Health Solutions. We have a program grant across Alberta. So Edmonton and
Calgary primarily is leading. Our key focus in quality improvement has been on acute stroke and
improving the speed of delivery of alteplase or tPA, which is the clot-busting medicine.
In Alberta, there are 15 designated primary stroke centers where there's an available CT scanner,
a team, and a protocol to give tPA. And there are two comprehensive stroke centers which can provide
all manner of intervention and surgical stroke care. Those are in Calgary and Edmonton. So what
we're working with all of these 17 sites to try to achieve, ultimately, a target average door-to-
needle time, the median door-to-needle time of 30 minutes or less. We have an interim target of 45
minutes and essentially we're trying to bring it down from its former average, which was around
70 minutes in the province. So we have now safely and well achieved the 45-minute goal and we're
working hard to try to get the times below 30 minutes. When you think about that again, coming
back to my previous idea of every minute is 2 million neurons, so 15 minutes saved is 30 million
neurons. So you can see that it's important. Every one of those minutes counts. So my hope is
that we're able to translate so many of the advances we've seen in stroke care into routine,
real life, and common practice all across Alberta. It's a big, big dream because there's still a
large gap between what is known about how patients could be treated and how they're actually treated
everywhere. So in the two academic centers, there's lots of resource. There's lots of people
with knowledge and there's lots of imaging availability and so it's possible to treat
people at the highest level at these centers. At the smaller places, it's just not the same.
The same expertise and training is not available, the same resource is not available,
but we have capacity to close that gap. We can bring treatment to people and we'll see less,
ultimately, that will result in less disability and burden from stroke. I mean, stroke is
devastating, right? I would say that the evolution of care in the last, even the last few years with
endovascular treatments that we played a big role in with the ESCAPE trial from here
is amazing, right? Ten years ago, I would be treating people, they have a big, huge
clot where the TPA, the clot buster, you know, it works sometimes but not that well. It works
really well for more moderate or smaller size clots and the big clots, these people were
devastated, right? They would either die or they would be left with massive disability and
often end up going to a nursing home, most often. And, you know, this week in Calgary, we treated
eight people with endovascular therapy, all of whom would have been destined for a nursing home
and seven walked out of hospital. It's unbelievable, right? So, the possibility for
massive change in what it actually means to an individual person is amazing. So,
knowing that, this kind of stuff where you're, if we can get everybody, you know, really focused on
this idea that it's fast treatment with TPA and then potentially move them on for endovascular
therapy, if we can do that successfully, it's going to take us probably a couple more years
to really embed this in Alberta. We really will be changing people's lives.
